RecruitingNCT05304988

Development and Validation of the EFT for Adolescents With Cancer

Development and Validation of the Exercise Fit Test (EFT) for Adolescents With Cancer


Sponsor

The Hong Kong Polytechnic University

Enrollment

400 participants

Start Date

Sep 7, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

There is increasing evidence of interventions shown to be effective to promote physical activity in adolescents with cancer. Nevertheless, adolescents with cancer become physically inactive after the end of the interventions. These interventions emphasized heavily on interventionists' role to assess adolescents' physical fitness and prescribe exercises. After the intervention, the adolescents were unable to follow the previous exercise prescriptions due to their changing medical conditions. To promote physical activity sustainably, it is vital to develop a patient-based assessment tool to allow adolescents with cancer to self-assess their own appropriate levels of physical activity that they could perform. However, a review of literature indicates a lack of such a tool.


Eligibility

Min Age: 13 YearsMax Age: 18 Years

Inclusion Criteria3

  • Aged 13-18
  • are diagnosed with cancer
  • are able to communicate in Cantonese and read Chinese

Exclusion Criteria1

  • Those with physical or cognitive impairments and learning problems, as identified from the medical records, were excluded. Also, those with medical advice that physical activity was not recommended or with detailed exercise prescriptions from physicians or physiotherapists during recruitment were excluded.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTesting of the EFT

Our team will develop specific questions in EFT. Then, subject will be invited to fill in a set of questionnaires covering demographic characteristics, EFT items and a numerical rating scale for pain scores. The physiotherapists will rate the subject with the most appropriate level of physical activity.


Locations(1)

Katherine Lam

Hong Kong, Hong Kong,China, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05304988


Related Trials